INEX 2026

Innovation Catalogue

Moringa extract based foot patch to treat diabetic foot ulcer

Industry 4.0

This invention relates to a novel polyherbal transdermal foot patch combining Moringa oleifera, curcumin, and black pepper essential oil for diabetic foot ulcers. Developed via solvent casting or 3D printing using HPMC/PVP polymers, the optimized F6 formulation demonstrates sustained drug release, Class V acute safety, and superior wound contraction with enhanced collagen deposition and tissue regeneration in vivo.

Innovator(s)
Dr. Kiranmai Mandava, Dr. Venkat Ratnam Devadasu, Kotla Vedhalatha
Organisation
St. Pauls College of Pharmacy
Country
India
Exhibition zone
Social Impact Lab
Technology Readiness Level
TRL 6 of 9
Edition
INEX 2026

About this innovation

1. Field of the Invention

The present invention pertains to the field of pharmaceutical formulations, specifically advanced transdermal and topical wound care dressings. More particularly, it relates to the design, optimization, and evaluation of a multi-targeted polyherbal matrix patch incorporating Moringa oleifera leaf extract, curcumin, and black pepper essential oil designed for the accelerated healing of chronic diabetic foot ulcers (DFUs).

2. Background and Prior Art Limitations

Diabetic foot ulcers represent a severe, non-healing complication of diabetes mellitus characterized by prolonged inflammation, excessive matrix metalloproteinase (MMP) activity, severe oxidative stress (ROS accumulation), microvascular insufficiency, and high susceptibility to polymicrobial biofilms. Conventional therapies—such as standard topical ointments, systemic antibiotics, and basic barrier dressings—suffer from short retention times, poor local vascular permeability in diabetic extremities, systemic toxicity risks, and single-target limitations that fail to address the multi-factorial pathology of chronic wounds.

3. Summary of the Invention and Formulation Strategy

To overcome these limitations, the invention provides a bio-functional, synergistic polyherbal transdermal patch combining the antioxidant, anti-inflammatory, and antimicrobial phytoconstituents of Moringa oleifera (rich in flavonoids and phenolic compounds) with synergistic agents like curcumin and black pepper essential oil.

· Preparation Methods: Eight formulations (F1–F8) were successfully developed using both the solvent evaporation/casting method and semi-solid extrusion 3D printing technology.

· Composition: Formulations incorporate varying amounts of Moringa oleifera (0.1 g to 0.8 g), fixed proportions of curcumin (0.25 g), black pepper essential oil (4 ml), polymers (HPMC K100 0.3 g, PVP 0.2 g), plasticizers, and surfactants within an ethanol-water (4:6) solvent system.

· Optimized Formulation (F6): Identified as the optimal candidate, F6 contains 0.6 g of Moringa oleifera. It displayed exceptional physicochemical properties, including minimal moisture content (0.22%), high drug content uniformity (101.1%), and controlled in vitro release profile reaching 101.8% for Moringa, 99.7% for curcumin, and 101.5% for black pepper essential oil within 12 hours.

4. Morphological and Structural Analysis (SEM Insights)

Scanning Electron Microscopy (SEM) evaluations comparing the cast F6 patch against the 3D-printed F6 patch reveal:

· Cast F6: Exhibits a predominantly continuous, compact polymeric surface with fine micro-porosity, uniform thickness (~395–408 microns), and limited void space, ensuring sustained and steady diffusion.

· 3D-printed F6: Features a topographically structured matrix displaying parallel deposition tracks, distinct interlayer interfaces, and interconnected microvoids, which effectively enhance fluid uptake and water vapor transmission rates (WVTR).

5. Preclinical Safety and Efficacy

· Toxicity: Acute oral toxicity studies following OECD Guideline No. 423 classified the polyherbal extract under Class V (with an LD50 of 4000 mg/kg), confirming its safety for biomedical applications.

· In Vivo Wound Healing: Evaluated in a high-fat diet and streptozotocin (HFD-STZ) induced diabetic rat model. The F6 patch significantly accelerated wound contraction, reducing the wound diameter down to 1.1 mm by Day 14—outperforming both the untreated disease control (3.0 mm) and standard neomycin treatment (2.5 mm).

· Histopathology: Microscopic examination confirmed that the polyherbal patch promotes superior tissue regeneration, enhanced re-epithelialization, reduced inflammatory cell infiltration, and well-organized collagen deposition with restored hair follicles and sebaceous glands.